文献速递术前评估与围术期医学疼痛医学

大麻使用与手术或介入操作中麻醉药物剂量的关系:单中心回顾性队列研究

Cannabis use and anaesthetic agent dosing in patients undergoing surgery or interventional procedures: a single-centre retrospective cohort study.
PubMed 文献 · Br J Anaesth · 2026-09-29

调整分析显示两类大麻使用均与丙泊酚和挥发性麻醉药剂量轻度升高相关,频繁使用者效应最强,但效应量小于既往报道。

要点

  • 非医疗大麻使用者丙泊酚剂量增加6.85 μg kg-1 min-1,医疗使用者增加2.87 μg kg-1 min-1。
  • 非医疗大麻使用者挥发性麻醉药增加0.01 MAC,医疗使用者增加0.02 MAC。
  • 每日娱乐性使用者丙泊酚剂量增加最明显,达8.41 μg kg-1 min-1。

核心结论

  • 大麻使用与非医疗和医疗使用者丙泊酚及挥发性麻醉药剂量轻度升高相关,但效应量小于既往报道,临床相关性有待未来研究。

研究设计与样本

  • 暴露分为非医疗大麻使用(娱乐性使用或大麻使用障碍)和医疗大麻素认证使用。
  • 主要结局为监测麻醉护理下丙泊酚剂量(μg kg-1 min-1)和全麻下年龄校正最低肺泡有效浓度(MAC)均值。

主要发现

  • 调整分析中,非医疗大麻使用与丙泊酚剂量增加6.85 μg kg-1 min-1相关(95% CI 6.07-7.63,P<0.001),医疗使用增加2.87 μg kg-1 min-1(95% CI 0.88-4.86,P=0.005)。
  • 非医疗大麻使用与挥发性麻醉药增加0.01 MAC相关(95% CI 0.01-0.02,P<0.001),医疗使用增加0.02 MAC(95% CI 0.01-0.03,P=0.002)。
  • 频繁使用者效应最强:每日娱乐性使用者丙泊酚剂量增加8.41 μg kg-1 min-1(95% CI 7.00-9.81,P<0.001)。
  • 在可比丙泊酚诱导剂量下,非医疗大麻使用者气管插管后心率增加更明显(+1.45次 min-1,95% CI 1.10-1.79,P<0.001)。

临床怎么用

  • 对有大麻使用史的患者,尤其每日娱乐性使用者,可预期丙泊酚和挥发性麻醉药需求量轻度增加。
  • 非医疗大麻使用者气管插管后心率反应可能更明显,需关注血流动力学管理。

局限性

  • 单中心回顾性设计可能限制结果外推性,且效应量小于既往报道,临床相关性尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is limited evidence that habitual cannabis consumption increases anaesthetic requirements. We hypothesised that cannabis use affects anaesthetic dosing among patients undergoing surgery or interventional procedures. METHODS: A total of 341 199 adult patients undergoing propofol sedation or volatile-based general anaesthesia at Beth Israel Deaconess Medical Center, Boston, USA, between 2008 and 2024 were included. The primary exposure was cannabis use, differentiated into medical or non-medical use (recreational use or cannabis use disorder). Primary outcomes were propofol dose (μg kg-1 min-1) for monitored anaesthesia care and mean end tidal age-adjusted minimum alveolar concentration (MAC) values for general anaesthesia. In multivariable analyses, we estimated the adjusted difference in mean primary anaesthetic agent dosing. RESULTS: A total of 23 896 patients (7.0%) were identified as non-medical cannabis users, and 3193 (0.9%) held a certification for medical cannabinoids. In adjusted analyses, both non-medical and medical cannabis use were associated with increased propofol doses (non-medical, +6.85 μg kg-1 min-1, 95% CI 6.07-7.63, P<0.001; medical, +2.87 μg kg-1 min-1, 95% CI 0.88-4.86, P=0.005) and doses of volatile anaesthetics (non-medical, +0.01 MAC, 95% CI 0.01-0.02, P<0.001; medical, +0.02 MAC, 95% CI 0.01-0.03, P=0.002). Estimated effects were strongest among frequent users (daily recreational users, +8.41 μg kg-1 min-1 propofol, 95% CI 7.00-9.81, P<0.001). At comparable propofol induction doses, non-medical cannabis users experienced greater heart rate increase after tracheal intubation (+1.45 beats min-1, 95% CI 1.10-1.79, P<0.001). CONCLUSIONS: Cannabis use was associated with modestly higher propofol and volatile anaesthetic doses. However, effect sizes were smaller than previously reported, and future studies should investigate the clinical relevance.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Ratajczak N, Ahrens E, Wachtendorf LJ, et al. Cannabis use and anaesthetic agent dosing in patients undergoing surgery or interventional procedures: a single-centre retrospective cohort study. Br J Anaesth. 2026. PMID: 42810868. doi:10.1016/j.bja.2026.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。